Follow
Ebtesam Al-Najjar,MD
Ebtesam Al-Najjar,MD
Houston Methodist Hospital
Verified email at houstonmethodist.org
Title
Cited by
Cited by
Year
Gemcitabine and cisplatin as neo-adjuvant for cholangiocarcinoma patients prior to liver transplantation: case-series
M Abdelrahim, H Al-Rawi, A Esmail, J Xu, G Umoru, F Ibnshamsah, ...
Current Oncology 29 (5), 3585-3594, 2022
172022
Pancreatic tumorigenesis: Precursors, genetic risk factors and screening
M Badheeb, A Abdelrahim, A Esmail, G Umoru, K Abboud, E Al-Najjar, ...
Current Oncology 29 (11), 8693-8719, 2022
102022
Thymoquinone’s antiviral effects: it is time to be proven in the covid-19 pandemic era and its Omicron variant surge
M Abdelrahim, A Esmail, N Al Saadi, E Zsigmond, E Al Najjar, D Bugazia, ...
Frontiers in Pharmacology 13, 848676, 2022
102022
Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation
A Esmail, M Badheeb, B Alnahar, B Almiqlash, Y Sakr, B Khasawneh, ...
Cancers 16 (11), 1946, 2024
32024
The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma
A Esmail, M Badheeb, BW Alnahar, B Almiqlash, Y Sakr, E Al-Najjar, ...
Pharmaceuticals 17 (7), 2024
12024
Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments
D Bugazia, E Al-Najjar, A Esmail, S Abdelrahim, K Abboud, A Abdelrahim, ...
Frontiers in Oncology 14, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–6